Qihan Biotech Announces The Completion Of Pre-Series B Financing For Developing Stem Cell-Derived Cell Therapy Products With High-Throughput Multiplexable Genome Editing
Round Type
Series B
HangzhouBiotechnologyHealth CareMedicalTherapeuticsInvestors
Description
Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to cell therapies and organ transplantation, today announced the successful completion of a pre-Series B financing exceeding $16 million funded by a new investor, Zhejiang Industrial Fund Co., Ltd., with participation from other existing investors. The combined funds from this financing round and the company's reserves will provide ample capital to support the rapid product iteration and global development of gene-edited stem cell products by Qihan in the next four years.
Quick answer
Qihan Biotech raised an undisclosed amount in a Series B round, dated September 23, 2023. Investors: Zhejiang Industrial Fund Co., Ltd. Qihan Biotech is based in Hangzhou, Zhejiang, China.
- How much did Qihan Biotech raise?
- Qihan Biotech raised an undisclosed amount in a Series B round on September 23, 2023.
- Who invested in Qihan Biotech?
- Zhejiang Industrial Fund Co., Ltd. is named as investors in this round.
- What does Qihan Biotech do?
- Qihan Biotech is a biotechnology company applying genome-editing technology to develop novel cell therapies and organs for transplantation.
- Where is Qihan Biotech based and how big is it?
- Qihan Biotech is based in Hangzhou, Zhejiang, China.
- Who are the decision-makers at Qihan Biotech?
- Fundz holds 1 contact at Qihan Biotech. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Qihan Biotech that raised within 45 days of this round, from Fundz verified event records.
- Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
- Actym Therapeutics raised $60M (Series A) on October 18, 2023.
- Renibus Therapeutics raised an undisclosed amount (Series B) on September 12, 2023.
- Aptose Biosciences raised $3M (Seed) on September 6, 2023.
- Actimed Therapeutics raised $6.1M (Series A) on August 22, 2023.
- HeartBeat.bio raised $4.8M (Seed) on November 2, 2023.
Who to call at Qihan Biotech, and when
A new round usually means Qihan Biotech is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Qihan Biotech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Qihan Biotech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Qihan Biotech. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Qihan Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansQihan Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.